• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Persistent Oxidative Stress and Inflammasome Activation in CD14 high CD16 - Monocytes From COVID-19 Patients

tetano

Editor, Senior Moderator
Front Immunol


. 2022 Jan 14;12:799558.
doi: 10.3389/fimmu.2021.799558. eCollection 2021.
Persistent Oxidative Stress and Inflammasome Activation in CD14 [SUP]high[/SUP] CD16 [SUP]-[/SUP] Monocytes From COVID-19 Patients


Silvia Lucena Lage[SUP] 1 [/SUP], Eduardo Pinheiro Amaral[SUP] 2 [/SUP], Kerry L Hilligan[SUP] 2 3 [/SUP], Elizabeth Laidlaw[SUP] 1 [/SUP], Adam Rupert[SUP] 4 [/SUP], Sivaranjani Namasivayan[SUP] 2 [/SUP], Joseph Rocco[SUP] 1 [/SUP], Frances Galindo[SUP] 1 [/SUP], Anela Kellogg[SUP] 5 [/SUP], Princy Kumar[SUP] 6 [/SUP], Rita Poon[SUP] 7 [/SUP], Glenn W Wortmann[SUP] 8 [/SUP], John P Shannon[SUP] 9 [/SUP], Heather D Hickman[SUP] 9 [/SUP], Andrea Lisco[SUP] 1 [/SUP], Maura Manion[SUP] 1 [/SUP], Alan Sher[SUP] 2 [/SUP], Irini Sereti[SUP] 1 [/SUP]



Affiliations

Abstract

The poor outcome of the coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, is associated with systemic hyperinflammatory response and immunopathology. Although inflammasome and oxidative stress have independently been implicated in COVID-19, it is poorly understood whether these two pathways cooperatively contribute to disease severity. Herein, we found an enrichment of CD14[SUP]high[/SUP]CD16[SUP]-[/SUP] monocytes displaying inflammasome activation evidenced by caspase-1/ASC-speck formation in severe COVID-19 patients when compared to mild ones and healthy controls, respectively. Those cells also showed aberrant levels of mitochondrial superoxide and lipid peroxidation, both hallmarks of the oxidative stress response, which strongly correlated with caspase-1 activity. In addition, we found that NLRP3 inflammasome-derived IL-1β secretion by SARS-CoV-2-exposed monocytes in vitro was partially dependent on lipid peroxidation. Importantly, altered inflammasome and stress responses persisted after short-term patient recovery. Collectively, our findings suggest oxidative stress/NLRP3 signaling pathway as a potential target for host-directed therapy to mitigate early COVID-19 hyperinflammation and also its long-term outcomes.

Keywords: CD14highCD16− monocytes; COVID-19; NLRP3 inflammasome; lipid peroxidation; oxidative stress.
 
Back
Top Bottom